Kolexia
Gravelle Pauline Médecine générale
Gravelle Pauline
Médecine générale
Hôpital Avicenne
Bobigny, France
53 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome folliculaire Maladie de Hodgkin Lymphome B Lymphome malin non hodgkinien Lymphome plasmoblastique Tumeurs hématologiques Infections à virus Epstein-Barr Lymphome B diffus à grandes cellules

Collaborateurs

Voir plus
Laurent Camille
Laurent Camille
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
Ysebaert Loic
Ysebaert Loic
Oncopole Toulouse, Toulouse, France
Rossi Cedric
Rossi Cedric
Hôpital François Mitterrand, Dijon, France
Brousset Pierre
Brousset Pierre
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France

Industries

Voir plus
Roche
1 collaboration(s)
Dernière en 2016
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
A Single Cell Atlas of Diffuse Large B Cell Lymphomas Reveals Distinct Cellular States Predictive of Outcomes
65th ASH Annual Meeting Abstracts   02 novembre 2023
Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine.
Journal for immunotherapy of cancer   31 octobre 2023
An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread: A Phase 1/2 First-in-Human Study of BMS-986258 Alone and in Combination With Nivolumab in Advanced Malignant Tumors
Essai Clinique (BMS)   27 septembre 2023
TAyloring LYmphoma therapy with Immune Escape Signatures from 3D avatars of B-cell NHL
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
Study of the efficacy of novel bispecific antibodies targeting immune checkpoints in a 3D model of B non-Hodgkin lymphoma
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
A Study to Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies: A Phase 1/2a Dose Escalation and Cohort Expansion Study of the Safety, Tolerability, and Efficacy of Anti-LAG-3 Monoclonal Antibody (Relatlimab, BMS-986016) Administered Alone and in Combination With Anti-PD-1 Monoclonal Antibody (Nivolumab, BMS-936558) in Relapsed or Refractory B-Cell Malignancies
Essai Clinique (BMS)   20 mars 2023
Single-cell spatial explorer: easy exploration of spatial and multimodal transcriptomics.
BMC bioinformatics   27 janvier 2023
Histological Subtypes Drive Distinct Prognostic Immune Signatures in Classical Hodgkin Lymphoma.
Cancers   06 octobre 2022
Baseline SUVmax is related to tumor cell proliferation and patient outcome in follicular lymphoma.
Haematologica   01 janvier 2022
Phased differentiation of γδ T and T CD8 tumor-infiltrating lymphocytes revealed by single-cell transcriptomics of human cancers.
Oncoimmunology   18 septembre 2021